Small-Cap Momentum Watch: Upcoming Catalysts for August 10–14
8/9/20266 min read
From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.
--
Companies Participating at Canaccord Genuity’s 46th Annual Growth Conference 2026
Canaccord Genuity’s 46th Annual Growth Conference will take place August 11–13, 2026, at the InterContinental Boston in Boston, Massachusetts. The conference brings together institutional investors, financial sponsors, and more than 400 public and private companies across Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail, featuring company presentations, investor meetings, and networking opportunities focused on growth strategies, industry trends, and investment opportunities.
KOPN, BAER, QTRX, ATHE, CRVO, CRDL, CMRC, TNYA, XTNT, LUCD, PAVM, ARBE, ENTX, OCGN, HOVR, TLSI, CLNN, BHST, RPAY, PACB, LUNG, XGN, CVRX, APYX, NAGE, CSHR, CLOV, GUTS, CGC, FABC, FLNT, BLND, SEER, LAW, VERU, KRMD, DIBS, HURA, KAZR, TELA
Other Companies with Material Events This Week
● NRXP – Will host a conference call and Q&A on August 10, 2026 at 8:30 a.m. ET to discuss the FDA’s completion of first-cycle review of its ANDA for preservative-free ketamine. Management will address the regulatory path toward potential approval and commercial launch plans.
● MODD – Will exhibit at the Association of Diabetes Care & Education Specialists 2026 Annual Conference in Columbus, Ohio, from August 7–10, 2026, showcasing live demonstrations of the Pivot tubeless insulin patch pump. The event is intended to support customer engagement and lead generation ahead of a planned October commercial launch across five U.S. markets.
● LUCD – Will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, with virtual one-on-one investor meetings.
● PAVM – Will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, with virtual one-on-one investor meetings.
● GUTS – Will participate in the Needham & Company MedTech & Diagnostics 1x1 Conference from August 10–11, 2026, conducting one-on-one meetings with investors.
● CNCK – CEO Pascal St-Jean and CFO Jason Sandberg will participate in a fireside chat at the KeyBanc Capital Markets Technology Leadership Forum in Park City, Utah, on August 11, 2026 at 10:00 a.m. MT.
● KBSX – Will present at the Skyline Signature Series on August 11, 2026.
● ZIP – Will present and host individual and small-group investor meetings at the KeyBanc Technology Leadership Forum on August 11, 2026. The presentation is scheduled for 12:00 p.m. PT, or 3:00 p.m. ET, and will be webcast live.
● RXRX – Will participate in Bank of America’s 2026 SMID Cap Executive Insights Event on August 11, 2026.
● ENGN – Will host a virtual key opinion leader event on August 11, 2026 at 11:00 a.m. ET focused on the evolving non-muscle invasive bladder cancer treatment landscape. The event will address future treatment sequencing, community-urology practice considerations, pricing and reimbursement dynamics, and will conclude with a live Q&A.
● HKIT – Entered into a $20.0 million agreement to acquire all outstanding shares of Ju Fu Limited, which operates an advertising and digital marketing business through subsidiaries. Consideration includes up to $14.0 million in cash, including $11.0 million payable across two closings and up to $3.0 million of performance-based deferred cash, plus 4.0 million Class A ordinary shares subject to performance-based restrictions. The first closing is expected on or around August 11, 2026, subject to customary conditions.
● RPAY – CFO Rob Houser will host virtual investor meetings at the D.A. Davidson Virtual Small Cap Conference on August 11, 2026.
● ICU – Will sponsor an educational webinar titled “Rethinking Pediatric Sepsis-Associated AKI: What Clinicians Should Know About QUELIMMUNE” on August 11, 2026 from 12:00–1:00 p.m. ET. The program will focus on use of QUELIMMUNE, or SCD-PED, in critically ill pediatric patients with sepsis-associated acute kidney injury.
● IMDX – CEO Josh Riggs and CFO Andrea James will conduct virtual one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026.
● LIDR – CEO Matt Fisch will participate in a fireside chat at the J.P. Morgan Auto Conference in New York on August 12, 2026 at 2:20 p.m. ET.
● BCAR – CEO Hoansoo Lee will participate in Needham’s Virtual AI Infrastructure 1x1 Conference on August 12, 2026, conducting virtual one-on-one meetings with institutional investors.
● RAIN – Will host a live business update webcast on August 12, 2026 at 4:30 p.m. EDT to discuss recent progress.
● ECX – Management will present at the J.P. Morgan Auto Conference in New York from August 12–13, 2026.
● DGNX – Extended the long-stop date for its proposed acquisition of Resulticks from July 31 to August 12, 2026. The parties have secured $70 million in private funding commitments for the combined business and are completing final execution formalities. The transaction and financing remain subject to satisfaction or waiver of remaining conditions precedent.
● ASPI – Will host investor meetings at Citi’s 2026 Natural Resources Conference in Las Vegas, Nevada, on August 13, 2026.
● BIVI – Will participate in a RedChip Companies investor webinar on August 12, 2026 at 4:15 p.m. ET. President and CEO Cuong Do will review topline results from the Phase 2 SUNRISE-PD trial of bezisterim in early-stage Parkinson’s disease, including motor and non-motor findings and implications for a planned Phase 3 registrational strategy. Management will also discuss the ADDRESS-LC Phase 2 trial in Long COVID and development of BIV201 for complications of advanced liver disease.
● MSS – A federal court settlement hearing is scheduled for August 12, 2026 regarding proposed resolution of pending stockholder derivative litigation. The proposed settlement includes five years of corporate governance reforms and a $400,000 payment for plaintiffs’ attorneys’ fees and expenses funded by insurers, subject to court approval.
● RNXT – Will participate in a JonesTrading webinar on August 13, 2026 at 1:30 p.m. ET with oncology key opinion leaders to discuss the evolving pancreatic cancer treatment landscape, its Trans-Arterial Micro-Perfusion platform, commercial use of RenovoCath, and the ongoing Phase III TIGeR-PaC trial evaluating intra-arterial gemcitabine for locally advanced pancreatic cancer.
● MOBX – Will host a strategic update call on August 13, 2026 at 4:15 p.m. ET. CEO Phil Sansone will discuss recent progress and strategic repositioning around four national-security focus areas: critical resources and advanced materials; defense, aerospace and autonomous systems; energy, water and critical infrastructure; and digital infrastructure and strategic technologies.
● HTCR – Agreed to sell its entire 51% interest in Heartcore Luvina Vietnam to its joint-venture partner for JPY 29.0 million, approximately $184,093. Closing is expected on or before August 14, 2026.
● OSRH – Set August 14, 2026 as the record date for its Shareholder Loyalty Contingent Value Rights program. Enrolled holders of record are eligible to receive one CVR per common share and may receive additional common shares at no cost if specified closing-price thresholds are achieved at four measurement dates over the following 12 months. Nasdaq has verbally indicated that it does not intend to apply an ex-date or mechanical downward price adjustment in connection with the CVR distribution or subsequent share deliveries, although securities-law requirements remain subject to the ongoing regulatory process.
● FLZH – Entered into a term sheet to acquire a 51% controlling interest in Bongo Holdings based on a $35.0 million pre-money valuation. Proposed closing consideration is approximately $25.7 million, including about $15.4 million of primary capital and $10.3 million of secondary consideration, with 60% payable in cash and 40% in equity, subject to adjustments. Continuing management may also earn up to $12.0 million over three years based on revenue and EBITDA targets. The parties are targeting definitive agreements by August 15, 2026 and a closing by September 15, subject to due diligence, financing, approvals, definitive documentation, and other customary conditions.
● AREC – Declared a special cash dividend of $0.0431 per share, payable August 25, 2026 to shareholders of record as of August 15, 2026.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.